Other Briefings
How the SGX–Nasdaq Dual-Listing Bridge Shapes Capital-Raising Options for Global Issuers
Foreign investors can assess how the SGX–Nasdaq dual-listing bridge influences valuation signals, market scale, and issuer positioning ahead of its launch.
How Much Disclosure is Optimal Under Singapore’s ACRA and MAS Rules
Companies should calibrate disclosure under ACRA and MAS to meet regulatory expectations, maintain governance credibility and protect sensitive information.
Singapore GDP 2040: What Investors Should Know
Singapore’s GDP may reach US$1.4 trillion by 2040 — see how policy, sectors, and currency shifts will shape investor decisions.
Should You Invest in Methanol and Ammonia Bunkering in Singapore
Methanol and ammonia are transforming Singapore’s bunkering sector, offering new opportunities and risks for early-stage investors.
Setting Up a Regional Treasury Center in Singapore
Singapore offers unmatched stability, incentives, and liquidity depth for regional treasury centers managing Asia-Pacific cash and risk.
How Can Companies Establish Tax Residency in Singapore to Access Treaty Relief?
Foreign investors can access treaty relief and lower tax rates by establishing genuine management and control in Singapore.
GST in Singapore: When Overseas Vendors Must Register and Collect Tax
Understand Singapore’s GST rules for overseas vendors, registration thresholds, compliance duties, and filing obligations.
How Much Paid-Up Capital Should Foreign Investors Commit in Singapore?
Foreign investors should know how much paid-up capital to commit in Singapore to meet banking, licensing, and tax requirements.
Strategic Multi-Currency Cash Management in Singapore
Multi-currency cash management in Singapore helps investors and executives balance risk, control liquidity, and support growth.
Cell and Gene Therapy Manufacturing in Singapore: An Investor’s Operating Thesis
Explore investment pathways in Singapore’s cell and gene therapy sector, from facilities to CDMOs, with tax and regulatory insights.
